Dr. Yadav has a long history of innovation and commercialization of novel technology focused on the development of new treatments for disease. Jay is an interventional cardiologist and founder of a number of successful companies: CardioMEMS acquired by St. Jude Medical; Angioguard, Inc. acquired by Johnson & Johnson; first investor and director of SMART Therapeutics acquired by Boston Scientific. Jay has authored over 300 peer-reviewed publications, 2 books, and over 40 patents. His scientific and entrepreneurial work has been widely recognized: American Heart Association Top Ten Scientific Advances, 2003; Ellis Island Medal of Honor, 2004; 50 Best Doctors in the History of the Cleveland Clinic, 2011; Ernst and Young Entrepreneur of the Year (healthcare), 2011; Intel Innovation Award, 2011; his procedure for stroke treatment became a Class I recommendation of the American Heart Association and the American College of Cardiology, 2011; American Heart Association Honoree, 2016. He serves on a […]

Mr. Roth, JD, MS, BS, brings 20+ years of product development experience with 24 patents. At Icon Interventional Systems, he led the development of the MoRe alloy. Previously, he contributed to innovations like the Onyx embolic system and launched products generating $125M annually at Cordis (Johnson & Johnson). Admitted to the Georgia and New Jersey Bars, he holds degrees in Law (Rutgers), Biomedical Engineering (UT), and Mechanical Engineering (Polytechnic).

Mahesh Krishnan brings 25 years of healthcare industry experience. Before MiRus, he was VP of Orthopedic CT at Carestream Health and led spine business growth at DePuy Synthes (J&J). He has held leadership roles in global marketing (Philips), P&L management (Alliance Healthcare), and sales operations (Philips and Marconi Medical). Mahesh holds a BS in EE (University of Madras), MS in BME (University of Kentucky), and an MBA in Finance (Case Western Reserve).  

Mr. Toney joined MiRus as CFO in February 2022.  Prior to joining MiRus, David served in Senior Financial and Operations roles for Mohawk (NYSE MHK) a building products company for 16 years. In addition, earlier in his career David served in various finance, accounting, and product marketing positions with a leading storage company, Seagate Technology (Nasdaq STX) and an Optical Router startup, Chiaro Networks.  David was recognized as the 2014 Finance Leader of the Year for Corporate Planning & Strategy from Georgia State University and he supports his local community and led Mohawk’s 2015 companywide United Way Campaign. David holds a MBA-Finance from Oklahoma City University, a BBA-Accounting from the University of Oklahoma, and passed the Certified Public Accountants exam.    

Dennis Moreno brings over twenty years in engineering experience, he began by working on SpaceShipOne’s Hybrid Rocket Propulsion competition for the Ansari X-Prize held by Scaled Composite. Dennis has also competed in the hit tv show BattleBots. He then moved into the medical device space where’s he’s developed vascular catheters and pioneered NOTES instrumentation for non-invasive surgery. Prior to MiRus he served as the technical lead in upper extremity orthopedics at Skeletal Dynamics in Miami, FL. Dennis holds a BS in Mechanical Engineering from FIU in Miami, FL.    

Mr. Gray has 25+ years of experience in orthopedic, spine and extremity at Zimmer, Abbott, Exactech, and RTI with a demonstrated history of planning and implementing successful global research and development organizational strategies. His experience spans the entire spectrum from concept generation to product support in the field, post launch. He has expertise in budget management, program and portfolio management, design controls, IP generation, licensing and acquisition, and project team process experience with over 25 patents.  Mr. Gray earned his BS in mechanical engineering from the University of Texas.    

Mr. Bauman has over ten years of global medical device experience focused on development, regulatory, reimbursement, and commercialization strategies for new cardiovascular, orthopedic, and spine products. This includes several successful US FDA regulatory submissions (510(k)’s, IDE’s, PMA’s) and EU filings (Technical Files, Design Dossiers), successful international clinical trial operations management and execution, and securing favorable reimbursement status for new medical technologies at the national coverage level. Mr. Bauman earned a BS in chemistry from Emory University and a BS in biomedical engineering from the Georgia Institute of Technology and a MS in regulatory science from Johns Hopkins University.  

Mrs. Cowart is a seasoned clinical affairs specialist who followed a successful 25-year nursing career in cardiovascular care with 20 years in the medical device industry. She most recently served as Director of Heart Failure at CardioMEMS, Inc. where she was responsible for managing clinical trials, supporting product development, regulatory and commercialization strategies. Mrs. Cowart earned a BS in Nursing from Emory University and a MSN from Georgia State University.